P. Moynagh

Cancer Research · 2005–2006

A researcher in the Science corpus: 2 papers; trusts 7 researchers and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

Whom P. Moynagh trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. Yumi Yamamoto
  2. M. Karin
  3. R. Gaynor
  4. T. Brummelkamp
  5. Tony T. Huang
  6. F. Greten
  7. A. Israël

Papers from P. Moynagh's perspective

Ordered by how strongly the researchers P. Moynagh trusts endorse each paper. Same corpus, a different order for every researcher.

  1. TAK1 is a ubiquitin-dependent kinase of MKK and IKK (Nature)
  2. Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-κB (Nature)
  3. NF-κB in cancer: from innocent bystander to major culprit (Nature Reviews. Cancer)
  4. CYLD is a deubiquitinating enzyme that negatively regulates NF-κB activation by TNFR family members (Nature)
  5. A nucleosomal function for IκB kinase-α in NF-κB-dependent gene expression (Nature)
  6. TAB2 and TAB3 activate the NF-kappaB pathway through binding to polyubiquitin chains. (Molecules and Cells)
  7. NF-κB-Inducing Kinase Regulates the Processing of NF-κB2 p100
  8. Regulation of Toll/IL-1-receptor-mediated gene expression by the inducible nuclear protein IκBζ (Nature)
  9. Activation by IKKα of a Second, Evolutionary Conserved, NF-κB Signaling Pathway (Science)
  10. Therapeutic potential of inhibition of the NF-kappaB pathway in the treatment of inflammation and cancer. (Journal of Clinical Investigation)

Their papers